Private Capital Management (Colorado)’s iShares Biotechnology ETF IBB Stock Holding History

Private Capital Management (Colorado)’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$29.2K	Hold	221	–	–	0.01%	179
2024 Q3	$32.2K	Hold	221	–	–	0.01%	241
2024 Q2	$30.3K	Hold	221	–	–	0.01%	198
2024 Q1	$30.3K	Hold	221	–	–	0.01%	208
2023 Q4	$30K	Hold	221	–	–	0.01%	189
2023 Q3	$27K	Hold	221	–	–	0.01%	183
2023 Q2	$28.1K	Hold	221	–	–	0.01%	174
2023 Q1	$28.5K	Buy	+221	New	+$28.9K	0.01%	183

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Private Capital Management (Colorado)'s IBB Position: Q4 2024 in Review

Private Capital Management (Colorado) held its iShares Biotechnology ETF (IBB) position steady in Q4 2024 at 221 shares worth $29.2K. The position accounts for 0.01% of the portfolio, ranked #179.

Private Capital Management (Colorado) first reported a position in IBB in Q1 2023 and has held it in 8 quarters since. The position peaked at $32.2K in Q3 2024. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

Private Capital Management (Colorado) held 221 shares of iShares Biotechnology ETF worth $29.2K as of Q4 2024.
Private Capital Management (Colorado) left its iShares Biotechnology ETF share count unchanged in Q4 2024.
iShares Biotechnology ETF made up 0.01% of Private Capital Management (Colorado)'s portfolio in Q4 2024, its #179 holding.
Private Capital Management (Colorado) first reported a position in iShares Biotechnology ETF in Q1 2023 and has held it in 8 quarters since.
Private Capital Management (Colorado)'s iShares Biotechnology ETF position peaked at $32.2K in Q3 2024.
874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Private Capital Management (Colorado)'s 13F filing for Q4 2024, filed 5 Feb 2025.